The global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020

[{"selector":"#anim-48be95ca-4ff9-45a7-95c5-422299668d7a [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

It is anticipated to hit $2.9 billion by 2030

[{"selector":"#anim-01d8686c-571a-4063-a92f-ea82b4a4b456 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The industry is registering a Compound Annual Growth Rate (CAGR) of 29.4% from 2021 to 2030

[{"selector":"#anim-b4af4850-568c-4312-a6a7-140af80fb64c [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market

[{"selector":"#anim-600771fe-c17e-44fb-89c2-f0fe0562d7e7 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Asia-Pacific is expected to grow at the fastest CAGR of 30.3% by 2030

[{"selector":"#anim-db6fbc5a-500d-4f6f-9111-bac69a1c90bd [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The growth in Asia-Pacific is driven by the increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis

[{"selector":"#anim-69862e33-e588-4de7-94d1-40f0e8317dfd [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The increase in the number of approvals for exosome therapeutics and diagnostics is expected to contribute to the growth of the market

[{"selector":"#anim-820f7d58-dd7d-4e77-b3d2-58fa905732e4 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

To Know more on Marketa Research Visit Us on